Quratis, an immune vaccine and immunotherapy company, announced to conduct a Phase 2a clinical trial of tuberculosis preventive vaccine for adults at Yonsei University Severance Hospital this January. The company acquired IND(Investigational New Drug) approval for the Phase 2a clinical trial of adult tuberculosis vaccine from the Ministry of Food and Drug Safety for the first time in Korea.